Screening of an epigenetic drug library identifies 4-((hydroxyamino)carbonyl)-n-(2-hydroxyethyl)-n-phenyl-benzeneacetamide that reduces melanin synthesis by inhibiting tyrosinase activity independently of epigenetic mechanisms
Research output: Contribution to journal › Article › peer-review
7Scopus
citations
Fingerprint
Dive into the research topics of 'Screening of an epigenetic drug library identifies 4-((hydroxyamino)carbonyl)-n-(2-hydroxyethyl)-n-phenyl-benzeneacetamide that reduces melanin synthesis by inhibiting tyrosinase activity independently of epigenetic mechanisms'. Together they form a unique fingerprint.